ArticleDiagnostic pathology2008
Adamantinoma: a clinicopathological review and update.
Article in Diagnostic pathology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 113 citations in OpenAlex.
- CT-guided bone biopsies with non-diagnostic results in pediatric patients-a multi-institutional 10-year retrospective review.European radiology · 2026Article
- Imaging Analysis for Metastatic Risk Assessment in Adamantinoma: The Aid of Radiology in the Absence of a Histological Grading-An MRI-Based Risk Model Proposal.Diagnostics (Basel, Switzerland) · 2025Article
- Conventional radiography for the assessment of focal bone lesions of the appendicular skeleton: fundamental concepts in the modern imaging era.Skeletal radiology · 2025Review
- Bone lesions of the tibia: Multimodal iconographic review and diagnostic algorithms, Part 1: Diagnostic algorithms, dysplasia and diaphyseal lesions.European journal of radiology open · 2025Review
- Meta-analysis of 65 Adamantinoma case reports: Unveiling symptomatology, demographics, and treatment outcomes in contrast to prior understandings.Journal of orthopaedics · 2025Review
- Dedifferentiated adamantinoma of long bones: a case report and literature review.Frontiers in oncology · 2025Article
- Adamantinoma: A SEER-based Epidemiological Analysis.Indian journal of surgical oncology · 2024Article
- Persistent Challenges: A Recurrent Adamantinoma - Case Report.Journal of orthopaedic case reports · 2024Article
- Rare Case of Recurrent Adamantinoma of the Tibia: Limited Efficacy of Pazopanib as a Standalone Treatment.The American journal of case reports · 2024Article
- Unusual presentation of adamantinoma with synchronous involvement of entire-lengths of the tibia and fibula in an elderly man: A case report.International journal of surgery case reports · 2024Article
- Article
- Adamantinoma Metastasis to the Pelvis and Ovaries: A Case Report and Literature Review.Cureus · 2023Article
- Adamantinoma: A review of the current literature.Journal of bone oncology · 2023Review
- Rapidly Progressive Classic Adamantinoma of the Spine: Case Report and Literature Review.Frontiers in oncology · 2022Article
- Adamantinoma: metastatic disease masquerading as a gynaecological malignancy.BMJ case reports · 2021Article
- Hemi-tibia allograft and free microvascularized fibula transplant reconstitute the tibia shaft with side to side healing: 7 year follow up of a 14-year-old boy with adamantinoma.Case reports in plastic surgery & hand surgery · 2021Article
- An unusual case of adamantinoma of long bone.Autopsy & case reports · 2021Article
- Fibula-Assisted Segment Transport (FAST) for Defect Reconstruction after Resection of Tibial Adamantinoma: Report of Two Treatments.Case reports in orthopedics · 2021Article
- Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases.The Journal of bone and joint surgery. American volume · 2020Article
- Adamantinomatous tumors: Long-term follow-up study of 20 patients treated at a single institution.Journal of surgical oncology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adamantinoma is a primary low-grade, malignant bone tumor that is predominantly located in the mid-portion of the tibia. The etiology of the tumor is still a matter of debate. The initial symptoms of adamantinoma are often indolent and nonspecific and depend on location and extent of the disease. Histologically, classic adamantinoma is a biphasic tumor characterized by epithelial and osteofibrous components that may be intermingled with each other in various proportions and differentiating patterns. To assure the histological diagnosis, pathologists should employ immunohistochemistry for demonstrating the sometimes sparse epithelial cell nests when the radiological features are suggestive of adamantinoma. There is paucity of compiled data over adamantinoma in the literature, hence authors tried to make a comprehensive review which must be of use to beginners and trained pathologists. Our objective is to further define the clinicoradiologic features and pathologic spectra of adamantinoma.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.